Docgo vs SBC Medical Group Holdings
Docgo is the larger business, with $322m of revenue in fiscal 2025 against $174m for SBC Medical Group Holdings (1.9 times as much). SBC Medical Group Holdings grew faster (-15.5% against -47.7%). SBC Medical Group Holdings kept more of each dollar of sales as profit: a net margin of 29.4% against -56.6%.
| Latest fiscal year | DocgoDCGO, 2025 | SBC Medical Group HoldingsSBC, 2025 |
|---|---|---|
| Revenue | $322m | $174m |
| Revenue growth | -47.7% | -15.5% |
| Net income | −$182m | $51.0m |
| Operating margin | — | 38.9% |
| Net margin | -56.6% | 29.4% |
| Return on equity | -78.5% | 23.0% |
| Free cash flow | $29.9m | $23.3m |
| Cash | $51.0m | $164m |
| Total debt | $287,323 | $42.8m |
| Debt to equity | — | 17.3% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $10.8m | $5.0m |
| Employees | 3,600 | 863 |
| Market value | $25.6m | $533m |
| Price vs our value range | — | Within our value range |
| Moat score | 18 (Weak) | — |
| Insider trades, 12 months | 0 buys, 1 sales | 0 buys, 3 sales |